Ocular Therapeutix IncNASDAQ:OCUL
- LAST PRICE4.9800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.7400/ 10
- Ask / Lots5.4000/ 5
- Open / Previous Close0.0000 / 4.9800
- Day Range---
- 52 Week Range
- Volume1
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OCUL |
|---|---|---|
| 09:32 ET | 35766 | 4.84 |
| 09:34 ET | 2309 | 4.83 |
| 09:36 ET | 1402 | 4.81 |
| 09:38 ET | 100 | 4.83 |
| 09:39 ET | 4440 | 4.835 |
| 09:41 ET | 12239 | 4.88 |
| 09:43 ET | 8462 | 4.8947 |
| 09:45 ET | 5853 | 4.9 |
| 09:48 ET | 3380 | 4.9027 |
| 09:50 ET | 3438 | 4.92 |
| 09:52 ET | 5311 | 4.93 |
| 09:54 ET | 2300 | 4.945 |
| 09:56 ET | 2266 | 4.975 |
| 09:57 ET | 4600 | 5 |
| 09:59 ET | 9873 | 5.0398 |
| 10:01 ET | 3588 | 5.02 |
| 10:03 ET | 2223 | 5.005 |
| 10:06 ET | 4946 | 5.02 |
| 10:08 ET | 4688 | 5.02 |
| 10:10 ET | 13938 | 5 |
| 10:12 ET | 4630 | 5 |
| 10:14 ET | 3700 | 5.005 |
| 10:15 ET | 10423 | 4.975 |
| 10:17 ET | 4051 | 4.995 |
| 10:19 ET | 1500 | 4.99 |
| 10:21 ET | 11473 | 4.995 |
| 10:24 ET | 3632 | 4.995 |
| 10:26 ET | 2900 | 5 |
| 10:28 ET | 1800 | 5 |
| 10:30 ET | 2849 | 5 |
| 10:32 ET | 8508 | 4.995 |
| 10:33 ET | 15799 | 5 |
| 10:35 ET | 57944 | 5.015 |
| 10:37 ET | 23783 | 5.065 |
| 10:39 ET | 6390 | 5.05 |
| 10:42 ET | 3928 | 5.065 |
| 10:44 ET | 4381 | 5.06 |
| 10:46 ET | 1450 | 5.1 |
| 10:48 ET | 3665 | 5.096 |
| 10:50 ET | 2899 | 5.1 |
| 10:51 ET | 2063 | 5.11 |
| 10:53 ET | 12467 | 5.1 |
| 10:55 ET | 3128 | 5.09 |
| 10:57 ET | 1835 | 5.09 |
| 11:00 ET | 2525 | 5.085 |
| 11:02 ET | 5530 | 5.085 |
| 11:04 ET | 4439 | 5.08 |
| 11:06 ET | 8470 | 5.06 |
| 11:08 ET | 6052 | 5.065 |
| 11:09 ET | 2083 | 5.07 |
| 11:11 ET | 2150 | 5.065 |
| 11:13 ET | 5312 | 5.075 |
| 11:15 ET | 6926 | 5.085 |
| 11:18 ET | 6606 | 5.08 |
| 11:20 ET | 1107 | 5.085 |
| 11:22 ET | 7713 | 5.11 |
| 11:24 ET | 2942 | 5.115 |
| 11:26 ET | 674 | 5.12 |
| 11:27 ET | 6667 | 5.12 |
| 11:29 ET | 4295 | 5.115 |
| 11:31 ET | 6416 | 5.1288 |
| 11:33 ET | 2633 | 5.115 |
| 11:36 ET | 2400 | 5.115 |
| 11:38 ET | 1297 | 5.115 |
| 11:40 ET | 1000 | 5.1114 |
| 11:42 ET | 15720 | 5.085 |
| 11:44 ET | 1142 | 5.085 |
| 11:45 ET | 900 | 5.085 |
| 11:47 ET | 9067 | 5.09 |
| 11:49 ET | 1030 | 5.085 |
| 11:51 ET | 9199 | 5.08 |
| 11:54 ET | 1494 | 5.09 |
| 11:56 ET | 6722 | 5.12 |
| 11:58 ET | 9148 | 5.115 |
| 12:00 ET | 5348 | 5.105 |
| 12:02 ET | 8634 | 5.115 |
| 12:03 ET | 6770 | 5.125 |
| 12:05 ET | 7398 | 5.12 |
| 12:07 ET | 8980 | 5.09 |
| 12:09 ET | 8489 | 5.085 |
| 12:12 ET | 5412 | 5.095 |
| 12:14 ET | 5206 | 5.085 |
| 12:16 ET | 11909 | 5.1 |
| 12:18 ET | 1100 | 5.095 |
| 12:20 ET | 1700 | 5.0999 |
| 12:21 ET | 4350 | 5.105 |
| 12:23 ET | 1487 | 5.105 |
| 12:25 ET | 5342 | 5.095 |
| 12:27 ET | 1506 | 5.095 |
| 12:30 ET | 618 | 5.095 |
| 12:32 ET | 14202 | 5.06 |
| 12:34 ET | 3569 | 5.065 |
| 12:36 ET | 4647 | 5.055 |
| 12:38 ET | 3398 | 5.055 |
| 12:39 ET | 700 | 5.05 |
| 12:41 ET | 5103 | 5.05 |
| 12:43 ET | 2932 | 5.035 |
| 12:45 ET | 1045 | 5.035 |
| 12:48 ET | 200 | 5.035 |
| 12:50 ET | 300 | 5.04 |
| 12:52 ET | 7273 | 5.035 |
| 12:54 ET | 2880 | 5.035 |
| 12:56 ET | 5100 | 5.04 |
| 12:57 ET | 1892 | 5.04 |
| 12:59 ET | 1110 | 5.03 |
| 01:01 ET | 3482 | 5.04 |
| 01:03 ET | 925 | 5.035 |
| 01:06 ET | 700 | 5.04 |
| 01:08 ET | 900 | 5.035 |
| 01:10 ET | 5050 | 5.03 |
| 01:12 ET | 900 | 5.04 |
| 01:14 ET | 2700 | 5.025 |
| 01:15 ET | 3227 | 5.0201 |
| 01:17 ET | 3960 | 5.025 |
| 01:19 ET | 1300 | 5.035 |
| 01:21 ET | 3458 | 5.035 |
| 01:24 ET | 200 | 5.03 |
| 01:26 ET | 500 | 5.035 |
| 01:28 ET | 4600 | 5.05 |
| 01:30 ET | 3378 | 5.035 |
| 01:32 ET | 5900 | 5.03 |
| 01:33 ET | 2652 | 5.025 |
| 01:35 ET | 2250 | 5.02 |
| 01:37 ET | 2855 | 5.025 |
| 01:39 ET | 2032 | 5.03 |
| 01:42 ET | 1600 | 5.035 |
| 01:44 ET | 3000 | 5.039 |
| 01:46 ET | 2550 | 5.0457 |
| 01:48 ET | 5383 | 5.06 |
| 01:50 ET | 6512 | 5.065 |
| 01:51 ET | 2312 | 5.0699 |
| 01:53 ET | 3933 | 5.06 |
| 01:55 ET | 2188 | 5.07 |
| 01:57 ET | 200 | 5.07 |
| 02:00 ET | 2943 | 5.055 |
| 02:02 ET | 900 | 5.055 |
| 02:04 ET | 1600 | 5.055 |
| 02:06 ET | 200 | 5.055 |
| 02:08 ET | 9726 | 5.04 |
| 02:09 ET | 3289 | 5.015 |
| 02:11 ET | 2600 | 5.01 |
| 02:13 ET | 3792 | 5.015 |
| 02:15 ET | 3262 | 5.01 |
| 02:18 ET | 1406 | 5.01 |
| 02:20 ET | 700 | 5.015 |
| 02:22 ET | 6825 | 5.015 |
| 02:24 ET | 6960 | 5.005 |
| 02:26 ET | 231 | 5 |
| 02:27 ET | 400 | 5.005 |
| 02:29 ET | 4103 | 4.99 |
| 02:31 ET | 900 | 4.995 |
| 02:33 ET | 5032 | 4.995 |
| 02:36 ET | 4458 | 5.02 |
| 02:38 ET | 4468 | 5.025 |
| 02:40 ET | 8976 | 5.015 |
| 02:42 ET | 4331 | 5.025 |
| 02:44 ET | 7962 | 5.05 |
| 02:45 ET | 1600 | 5.045 |
| 02:47 ET | 2526 | 5.04 |
| 02:49 ET | 6389 | 5.065 |
| 02:51 ET | 10467 | 5.05 |
| 02:54 ET | 650 | 5.06 |
| 02:56 ET | 1009 | 5.055 |
| 02:58 ET | 2000 | 5.055 |
| 03:00 ET | 7111 | 5.05 |
| 03:02 ET | 3661 | 5.05 |
| 03:03 ET | 2817 | 5.05 |
| 03:05 ET | 2401 | 5.045 |
| 03:07 ET | 4372 | 5.05 |
| 03:09 ET | 200 | 5.05 |
| 03:12 ET | 6607 | 5.035 |
| 03:14 ET | 3639 | 5.035 |
| 03:16 ET | 6965 | 5.06 |
| 03:18 ET | 5171 | 5.045 |
| 03:20 ET | 6635 | 5.05 |
| 03:23 ET | 402 | 5.05 |
| 03:25 ET | 6754 | 5.07 |
| 03:27 ET | 1000 | 5.065 |
| 03:30 ET | 2900 | 5.07 |
| 03:32 ET | 21604 | 5.06 |
| 03:34 ET | 3000 | 5.055 |
| 03:36 ET | 2766 | 5.05 |
| 03:38 ET | 1000 | 5.05 |
| 03:39 ET | 1356 | 5.05 |
| 03:41 ET | 14379 | 5.045 |
| 03:43 ET | 5863 | 5.04 |
| 03:45 ET | 31860 | 5.035 |
| 03:48 ET | 2575 | 5.03 |
| 03:50 ET | 29283 | 5.01 |
| 03:52 ET | 32824 | 5.005 |
| 03:54 ET | 9845 | 5 |
| 03:56 ET | 14652 | 5 |
| 03:57 ET | 40405 | 4.99 |
| 03:59 ET | 130509 | 4.98 |
Jun 5, 2024
Ocular Therapeutix(R) to Host Investor Day on June 13, 2024, from 7:30AM ET on Wednesday Jun 05, 2024 by Dow Jones
7:30AM ET on Wednesday Jun 05, 2024 by Dow Jones
Jun 4, 2024
Ocular Therapeutix(R) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Tuesday Jun 04, 2024 by Dow Jones
4:05PM ET on Tuesday Jun 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ocular Therapeutix Inc | 765.2M | -4.6x | --- |
Daiichi Sankyo Co Ltd | 72.9B | 55.2x | --- |
Theravance Biopharma Inc | 426.5M | -10.1x | --- |
EyePoint Pharmaceuticals Inc | 474.0M | -5.0x | --- |
Pliant Therapeutics Inc | 672.6M | -4.0x | --- |
Liquidia Corp | 1.1B | -8.8x | --- |
Company Information
Ocular Therapeutix, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye. Its first commercial drug product, DEXTENZA, is for the treatment of ocular inflammation and pain following ophthalmic surgery and ocular itching associated with allergic conjunctivitis. It is also developing two other clinical-stage assets, OTX-DED (dexamethasone intracanalicular insert) for the short-term treatment of the signs and symptoms of dry eye disease, and OTX-CSI (cyclosporine intracanalicular insert) for the chronic treatment of dry eye disease. It is conducting a pivotal Phase III clinical trial to evaluate AXPAXLI for the treatment of wet AMD. Its clinical portfolio also includes PAXTRAVA, which is in Phase III clinical development for the treatment of primary open-angle glaucoma (OAG) or ocular hypertension (OHT).
Contact Information
- Headquarters
- 15 Crosby DriveBEDFORD, MA, United States 01730
- Phone
- 781-357-4000
- Fax
- 781-357-4001
Executives
- Executive Chairman of the Board, President, Chief Executive Officer
- Pravin Dugel
- Chief Financial Officer
- Donald Notman
- Chief Technical Officer
- Peter Jarrett
- Chief Scientific Officer
- Jeffrey Heier
- General Counsel
- Philip Strassburger
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $765.2M |
|---|---|
Revenue (TTM) | $59.8M |
Shares Outstanding | 154.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.27 |
EPS | $-1.09 |
Book Value | $0.79 |
P/E Ratio | -4.6x |
Price/Sales (TTM) | 12.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -175.81% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
